Last reviewed · How we verify
NCT05143567
Hemostasis and Inflammation in COVID-19 Patients With Venous and Arterial Thrombotic Complications
NA trial testing standard of care anticoagulation in absence of thrombotic complications in Venous Thromboembolism in 150 participants. Completed in 23 July 2023.
23 July 2023
Quick facts
| Lead sponsor | Ryazan State Medical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 150 |
| Start date | 1 November 2021 |
| Primary completion | 23 July 2023 |
| Estimated completion | 23 July 2023 |
| Sites | 1 location across Russia |
Drugs / interventions tested
- standard of care anticoagulation in absence of thrombotic complications
- standard of care anticoagulation in presence of thrombotic complications
- standard of care anticoagulation in combination with elastic compression
Conditions studied
- Venous Thromboembolism — all drugs for Venous Thromboembolism →
- covid19 — all drugs for covid19 →
- Thrombosis — all drugs for Thrombosis →
Sponsor
Ryazan State Medical University
Who can join
Adults 18 to 80, any sex, with Venous Thromboembolism or covid19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is aimed at assessing the role of the activity of high-risk markers of thrombotic events (MCP-1, MIP1α, IP-10, phosphatedylserine, calreticulin) on the development of thrombotic complications in patients with COVID -19.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05143567
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Venous Thromboembolism
Currently open trials in the same condition.
- NCT07399977 — Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism · NA · recruiting
- NCT06861088 — The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer · Phase 3 · recruiting
- NCT07140523 — A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA · Phase 2 · recruiting
- NCT04211181 — CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism · NA · recruiting
- NCT06440694 — Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial) · Phase 3 · recruiting
Other Ryazan State Medical University trials
Trials by the same sponsor.
- NCT05920226 — Myocardial Fibrosis in Patients With Permanent Pacemakers · active not recruiting
- NCT06367166 — Effects of Bioflavanoids on Vascular Wall Remodeling in Patients With Varicose Veins · NA · active not recruiting
- NCT05933720 — Efficacy and Safety of the Regulatory Polypeptides in Patients With Peripheral Atherosclerosis. · NA · recruiting
- NCT06806371 — PREDICTORS of CARDIOVASCULAR OUTCOMES in INDIVIDUALS with DIFFERENT OBESITY PHENOTYPES · active not recruiting
- NCT05899920 — Clinical One-stage Controlled Study of reSistant Arterial Hypertension for the desiGning of a personAlized Approach to T · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05143567 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ryazan State Medical University
- Last refreshed: 18 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05143567.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing